Stay updated with breaking news from Ionis Core. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bard Financial Services Inc. decreased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 38.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 53,925 shares of the company’s stock after selling 33,970 shares during the period. Bard Financial Services Inc.’s holdings […]
Sanford C. Bernstein started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. The firm issued an underperform rating and a $31.00 price target on the stock. A number of other brokerages have also weighed in on IONS. SVB Leerink reduced their […]
Sanford C. Bernstein started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research note published on Tuesday, The Fly reports. The brokerage issued an underperform rating and a $31.00 target price on the stock. IONS has been the subject of a number of other reports. Barclays lowered their price target on […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has received a consensus rating of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating on the company. The average […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.